- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BrainLAB releases IGS product
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems based in Westchester, IL, announced June 2 a patient positioning technology to support radiosurgery for high-risk spinal tumors. The patient positioning system is
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems based in Westchester, IL, announced June 2 a patient positioning technology to support radiosurgery for high-risk spinal tumors. The patient positioning system is integrated into the Novalis Shaped Beam Surgery system. The BrainLAB technology confirms the location of the tumor prior to radiosurgery by comparing real-time images with a 3D model of the patient's anatomy created from images taken previously. Using the spine as a reference, the system precisely positions the patient's body for radiosurgery by repositioning the patient couch. The first clinical study, led by the Henry Ford Hospital radiosurgery team, demonstrated high precision and clinical effectiveness of extracranial radiosurgery in patients with spinal tumors.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
